is retatrutide on the market FDA has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers., "All of a sudden, you have Influencers are pushing suspicious peptides.

For employers who have opted not to cover GLP-1s yet, pressure from employees and HR teams is mounting

Final dosing will be confirmed after approval

Factors like adherence, protein intake, exercise, and baseline metabolic health determine where in that range youll land

Each additional receptor target adds both complexity and potential efficacy, which is reflected in both the clinical data and the manufacturing costs

However, at present primary care staff cannot prescribe GLP-1 RA for obesity and currently must refer patients to specialist weight management services

The 20mg vial at 8mg per week provides 2.5 weekly doses, covering about two and a half weeks per vial